PAR not yet [Two-Stage / GS Designs]

posted by The Outlaw Torn – Europe, 2011-10-25 10:57 (4559 d 15:11 ago) – Posting: # 7541
Views: 13,592

Hi Helmut,

Sorry for the delay (CPhI stuff) and thanks for the info.

We are involved in a project in which the CRO has proposed this study approach. My feedback was basically the same or similar (would I be ostracized if I said "essentially similar"?) to yours—as long as the consumer risk is preserved, I don't see why it wouldn't be okay to stop without penalty after the first stage if the BE study is successful (Potvin method C).

I'll make sure the CRO provides adequate justification in the protocol. Thanks for the feedback. If I get feedback from the authorities on this approach later on, I'll pass it on.

Complete thread:

UA Flag
Activity
 Admin contact
22,986 posts in 4,823 threads, 1,671 registered users;
71 visitors (0 registered, 71 guests [including 4 identified bots]).
Forum time: 02:09 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5